Ruth Gabizon

6.1k total citations · 2 hit papers
91 papers, 4.8k citations indexed

About

Ruth Gabizon is a scholar working on Molecular Biology, Nutrition and Dietetics and Neurology. According to data from OpenAlex, Ruth Gabizon has authored 91 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Molecular Biology, 50 papers in Nutrition and Dietetics and 39 papers in Neurology. Recurrent topics in Ruth Gabizon's work include Prion Diseases and Protein Misfolding (79 papers), Trace Elements in Health (45 papers) and Neurological diseases and metabolism (39 papers). Ruth Gabizon is often cited by papers focused on Prion Diseases and Protein Misfolding (79 papers), Trace Elements in Health (45 papers) and Neurological diseases and metabolism (39 papers). Ruth Gabizon collaborates with scholars based in Israel, United States and Greece. Ruth Gabizon's co-authors include Stanley B. Prusiner, Glenn C. Telling, James A. Mastrianni, Stephen J. DeArmond, Zeev Meiner, Michael P. McKinley, Michele Halimi, Darlene Groth, Albert Taraboulos and Fred E. Cohen and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Ruth Gabizon

90 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity

1996 688 citations Piero Parchi, Pasquale Montagna et al. profile →
Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein

1995 663 citations Ruth Gabizon, Stanley B. Prusiner et al. profile →

Peers

Countries citing papers authored by Ruth Gabizon

Since Specialization

Citations

This map shows the geographic impact of Ruth Gabizon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Gabizon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Gabizon more than expected).

Fields of papers citing papers by Ruth Gabizon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Gabizon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Gabizon. The network helps show where Ruth Gabizon may publish in the future.

Co-authorship network of co-authors of Ruth Gabizon

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Gabizon. A scholar is included among the top collaborators of Ruth Gabizon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Gabizon. Ruth Gabizon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Granagard administration prolongs the survival of human mesenchymal stem cells transplanted into a mouse model of multiple sclerosis 2024 ·Journal of Neuroimmunology ·Kati Frid, (unknown), (unknown), Orli Binyamin, (unknown), Ibrahim Kassis, (unknown), Ruth Gabizon	0
2	Nano-PSO Administration Attenuates Cognitive and Neuronal Deficits Resulting from Traumatic Brain Injury 2022 ·Molecules ·(unknown), Kati Frid, (unknown), Vardit Rubovitch, Ruth Gabizon, Chaim G. Pick	8
3	Delay of gCJD aggravation in sick TgMHu2ME199K mice by combining NPC transplantation and Nano-PSO administration 2020 ·Neurobiology of Aging ·Kati Frid, Orli Binyamin, (unknown), Ruth Gabizon	6
4	Brain targeting of 9c,11t-Conjugated Linoleic Acid, a natural calpain inhibitor, preserves memory and reduces Aβ and P25 accumulation in 5XFAD mice 2019 ·Scientific Reports ·Orli Binyamin, (unknown), Kati Frid, (unknown), Hanna Rosenmann, Ruth Gabizon	27
5	Identifying therapeutic targets and treatments in model systems 2018 ·Handbook of clinical neurology ·Corinne Ida Lasmézas, Ruth Gabizon	4
6	Continues administration of Nano-PSO significantly increased survival of genetic CJD mice 2017 ·Neurobiology of Disease ·Orli Binyamin, (unknown), Kati Frid, Liraz Larush, Shlomo Magdassi, Ruth Gabizon	16
7	Pomegranate seed oil nanoemulsions for the prevention and treatment of neurodegenerative diseases: the case of genetic CJD 2014 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown), Yael Friedman‐Levi, Liraz Larush, Kati Frid, Orli Binyamin, (unknown), Nina Fainstein, Haim Ovadia, Tamir Ben‐Hur, Shlomo Magdassi, Ruth Gabizon	79
8	Targeting of prion-infected lymphoid cells to the central nervous system accelerates prion infection 2012 ·Journal of Neuroinflammation ·Yael Friedman‐Levi, Romana Höftberger, Herbert Budka, (unknown), Oded Abramsky, Haim Ovadia, Ruth Gabizon	2
9	Induced Neuroprotection Independently From PrPSc Accumulation in a Mouse Model for Prion Disease Treated With Simvastatin 2008 ·Archives of Neurology ·Yaron Haviv, Dana Avrahami, Haim Ovadia, Tamir Ben‐Hur, Ruth Gabizon, Ronit Sharon	27
10	Characterization of light chain immunoglobulin in urine from animals and humans infected with prion diseases 2005 ·Journal of Neuroimmunology ·Zehavit Kariv-Inbal, Michele Halimi, (unknown), (unknown), Ruth Gabizon	10
11	PrPSc Incorporation to Cells Requires Endogenous Glycosaminoglycan Expression 2005 ·Journal of Biological Chemistry ·(unknown), Zehavit Kariv-Inbal, Marı́a Gasset, Ruth Gabizon	75
12	Dimethyl sulfoxide delays PrPsc accumulation and disease symptoms in prion-infected hamsters 2003 ·Brain Research ·Gideon M. Shaked, (unknown), Inbal Avraham, Esther Kahana, Ruth Gabizon	19
13	13 Inherited Prion Diseases 1999 ·Cold Spring Harbor Monograph Archive ·Pierluigi Gambetti, Robert B. Petersen, Piero Parchi, Shu G. Chen, Sabina Capellari, Lev G. Goldfarb, Ruth Gabizon, Pasquale Montagna, E Lugaresi, Pedro Piccardo, Bernardino Ghetti	3
14	Scrapie‐Infected Mice and PrP Knockout Mice Share Abnormal Localization and Activity of Neuronal Nitric Oxide Synthase 1999 ·Journal of Neurochemistry ·Gilmor I. Keshet, Haim Ovadia, Albert Taraboulos, Ruth Gabizon	56
15	Subcellular trafficking abnormalities of a prion protein with a disrupted disulfide loop 1999 ·FEBS Letters ·Anat Yanai, Zeev Meiner, (unknown), Ruth Gabizon, Albert Taraboulos	17
16	Familial Creutzfeldt-Jakob Disease: Codon 200 Prion Disease in Libyan Jews 1997 ·Medicine ·Zeev Meiner, Ruth Gabizon, Stanley B. Prusiner	52
17	Mutation in codon 200 and polymorphism in codon 129 of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease 1994 ·Philosophical Transactions of the Royal Society B Biological Sciences ·Ruth Gabizon, (unknown), Zeev Meiner, Irit Kahana, Esther Kahana, Yin Yao Shugart, Jürg Ott, Stanley B. Prusiner	16
18	Genetics and biochemistry of Creutzfeldt-Jakob disease in Libyan Jews 1994 ·Biomedicine & Pharmacotherapy ·Ruth Gabizon, Michele Halimi, Zeev Meiner	2
19	Mutation of the Prion Protein in Libyan Jews with Creutzfeldt–Jakob Disease 1991 ·New England Journal of Medicine ·Karen Hsiao, Zeev Meiner, Esther Kahana, (unknown), Irit Kahana, Dana Avrahami, G. Scarlato, Oded Abramsky, Stanley B. Prusiner, Ruth Gabizon	207
20	Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da 1988 ·Virology ·(unknown), Ellis S. Kempner, Darlene Groth, Ruth Gabizon, Stanley B. Prusiner	113

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact